Shopping Cart 0
Cart Subtotal
USD 0

University of Toronto - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

University of Toronto (UT) is an educational and research service provider that offers undergraduate and postgraduate courses in various fields. The university offers courses in various fields such as applied science and engineering, architecture, landscape, design, arts and science, continuing studies, school of dentistry education, forestry education. It provides services such as arts, science and business, music, physical education and health, law, medical radiation sciences, medicine, nursing, pharmacy, biochemistry, biology, cell and systems biology, chemical and physical sciences, among others. The university conducts research and development on the areas of psychology, biology, public health sciences, environment sciences and Alzheimer diseases. It partners with researchers, government and industries across Brazil and Italy for its research activities. UT is headquartered in Toronto, Ontario, Canada.

University of Toronto-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

University of Toronto, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Toronto, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Toronto, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Toronto, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Toronto, Medical Devices Deals, 2012 to YTD 2018 10

University of Toronto, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

University of Toronto, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Cyclica Enters into Agreement with University of Toronto 12

Celgene Partners with Recombinant Antibody Network 13

Edge Therapeutics Enters into Research and Discovery Agreement with St. Michael's Hospital 14

Blueline Bioscience Forms Joint Venture with University of Toronto and University Health Network 15

Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 16

Licensing Agreements 17

Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 17

Kolltan Pharma Enters Into Licensing Agreement With University of Toronto For Anti-KIT Antibodies And Related IP 18

Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 19

Asset Transactions 21

NovaDigm Therapeutics Acquires Rights to Beta-Mannan Trisaccharide Conjugate from University of Alberta, Louisiana State University School of Medicine and University of Toronto 21

Regen BioPharma to Acquire Cancer Stem Cell Intellectual Property from University of Toronto 22

University of Toronto-Key Competitors 23

University of Toronto-Key Employees 24

University of Toronto-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Affiliate 26

Joint Venture 26

Recent Developments 27

Strategy And Business Planning 27

Oct 11, 2017: University of Toronto and Medicxi launch Janpix to Advance Dual Impact Cancer Therapies 27

Government and Public Interest 28

Jul 24, 2018: CAMH-led collaboration will introduce a new model of early psychosis care across Ontario 28

Jul 18, 2018: U of T scientists uncover DNA 'shield' with crucial roles in normal cell division, the immune system and cancer 30

Jul 10, 2018: U of T researchers tackle type 1 diabetes with regenerative medicine technologies 32

Jun 13, 2018: Cryo-EM reveals interaction between major drug targets 35

Feb 20, 2018: Largest study of its kind finds alcohol use biggest risk factor for dementia 37

Feb 19, 2018: Government of Canada and Brain Canada announce a USD 10-million grant to establish a platform that will help researchers share data more widely and efficiently 38

Feb 06, 2018: U of T researchers develop new way to fill cavities that could reduce further decay 39

Feb 02, 2018: New joints research for arthritis suffers receive Connaught Innovation Award support 40

Nov 06, 2017: Scientists discover potential treatment to stop glaucoma in its tracks 42

Oct 13, 2017: Neurotechnological innovation and organ-on-a-chip engineering centres receive more than USD 10 million in new funding 44

Aug 30, 2017: Tracing single brain cancer cells simplifies complexity of incurable brain cancers, suggesting new treatments, international study finds 45

Mar 20, 2017: Canadian collaboration to accelerate development of cancer treatments 47

Mar 16, 2017: Prostate Cancer Clinical Trial Shows Treating With Precision Radiotherapy Reduces Course of Treatment by 50 Per Cent 49

Product News 50

Aug 28, 2018: Lung tissue chip offers rapid testing of anti-fibrotic drugs 50

Other Significant Developments 51

Jun 19, 2018: U of T grad s AI startup raises USD 1.5 million to accelerate cancer drug discovery 51

Sep 19, 2017: Google Glass app helps autistic children with social interactions 53

Appendix 54

Methodology 54

About GlobalData 54

Contact Us 54

Disclaimer 54


List Of Figure

List of Figures

University of Toronto, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Toronto, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Toronto, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Toronto, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Toronto, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Toronto, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

University of Toronto, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Toronto, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Toronto, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

University of Toronto, Pharmaceuticals & Healthcare, Key Facts 2

University of Toronto, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Toronto, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Toronto, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Toronto, Deals By Therapy Area, 2012 to YTD 2018 9

University of Toronto, Medical Devices Deals, 2012 to YTD 2018 10

University of Toronto, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Cyclica Enters into Agreement with University of Toronto 12

Celgene Partners with Recombinant Antibody Network 13

Edge Therapeutics Enters into Research and Discovery Agreement with St. Michael's Hospital 14

Blueline Bioscience Forms Joint Venture with University of Toronto and University Health Network 15

Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 16

Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 17

Kolltan Pharma Enters Into Licensing Agreement With University of Toronto For Anti-KIT Antibodies And Related IP 18

Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 19

NovaDigm Therapeutics Acquires Rights to Beta-Mannan Trisaccharide Conjugate from University of Alberta, Louisiana State University School of Medicine and University of Toronto 21

Regen BioPharma to Acquire Cancer Stem Cell Intellectual Property from University of Toronto 22

University of Toronto, Key Competitors 23

University of Toronto, Key Employees 24

University of Toronto, Other Locations 25

University of Toronto, Subsidiaries 25

University of Toronto, Affiliate 26

University of Toronto, Joint Venture 26

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

University of Toronto, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.